d.bakker
TL2 Moderator · Faro
Contributes reviews on supplier material. Based in Faro.
Joined 12 May 2025 · last posted 3d
79Posts here
3Topics
0Solutions
862Likes received
506Likes given
25Badges
189Days visited
2.6kPosts read
Recent activity
Full stream-
Revisiting: How this community labels and discusses unrefereed work Replied, post #34 · Evidence › Preprints · 25 Jul 2026 · 1 like Preprints for speed: some important preliminary findings are posted as preprints to disseminate quickly. That speed is useful but comes at the cost of not yet having…
-
Common supplements people ask about, assessed one at a time Replied, post #67 · Practice › Interactions · 19 Jul 2026 · 4 likes Worth separating two things that post #63 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
-
What to bring: records that a clinician can actually use — a second dataset Replied, post #48 · Clinical › Prescriber conversations · 18 Jul 2026 · 16 likes Understanding stopping rules: what would prompt stopping the compound? Adverse effect, lack of benefit after a defined time, or other reasons? Knowing in advance is…
-
What I would want from a home test that does not exist yet Replied, post #35 · Analytics › Home & field testing · 12 Jul 2026 · 4 likes post #34 answers the question as asked. The question underneath it is different. Enzyme assays: if you have an enzyme that reacts specifically with your compound, an…
-
Seven-day rolling means and why weekly readings mislead Replied, post #8 · Outcomes › Progress reports · 10 Jul 2026 · 4 likes Rate of change: reporting progress as "lost 5 kg in 12 weeks" is more useful than "currently at 82 kg" because the rate tells you whether the change is steady,…
-
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #95 · Safety › Contraindications · 2 Jul 2026 · 4 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Deletion sequences: expected mass shifts by residue — the long version Started this topic · Analytics › Impurities & related substances · 1 Jul 2026 · 3 likes On the subject in the title: Deletion sequences: expected mass shifts by residue — the long version Working notes rather than a conclusion. Working through the identity…
-
Ultrasound and skinfolds: operator dependence in practice Replied, post #27 · Outcomes › Body composition · 23 Jun 2026 · 18 likes Lean mass loss during rapid weight reduction: depends on protein intake, resistance training volume, and total energy deficit. Adequate protein and maintaining training…
-
Follow-up: Reconciling a label claim with a content assay Replied, post #26 · Analytics › COA interpretation · 18 Jun 2026 · 1 like Sterility testing is separate: chromatographic purity, mass spectrometry, and endotoxin testing all say nothing about whether a solution is sterile. If sterility…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #116 · Compounds › Tirzepatide · 2 Jun 2026 · 0 likes SURMOUNT-4 used a randomised withdrawal design: everyone titrated, then those on maintenance were randomised to continue or placebo. Continuation maintained effect;…
-
Five questions in one post gets you one answer — how to split them Replied, post #82 · Start Here › How to Ask · 16 May 2026 · 4 likes Disagreement-style questions: "I read this and it contradicts what I heard here, which is right?" is answerable. "Is this a bad idea?" without giving the context is not.
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #98 · Practice › Interactions · 4 May 2026 · 1 like Supplements and herbs: many have no established interaction. Some do. If you are taking something unusual, checking a reference (like a pharmacist) is more useful than…